RxDoctor Payments Data

Kelley Murphy, NP

Adult Health · South Yarmouth, MANPI 1720325632

Payments from drug & device makers

$427in general payments, 2019–2025

Across 20 payments — averaging $21.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$129
  • AstraZeneca$117
  • Lilly USA, LLC$78
  • Exact Sciences$55
  • Merck$18
  • Johnson & Johnson$16
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$427100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$427 in reported general payments places this provider in the 65th percentile of 671 adult health providers in Massachusetts.

See all adult health providers in Massachusetts

Medicare billing

Part B allowed, 2024
$131,536
Medicare patients
572
Services billed
3,231

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban53$75,778
JardianceEmpagliflozin23$26,558
XareltoRivaroxaban13$19,074
JanuviaSitagliptin Phosphate11$17,730
OzempicSemaglutide15$16,126
WegovySemaglutide11$14,541
OxycontinOxycodone Hcl17$11,397
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,470
Breo ElliptaFluticasone/Vilanterol14$6,547
Rosuvastatin Calcium200$5,232
Atorvastatin Calcium228$3,688
Fluticasone Propionate HfaFluticasone Propionate14$3,399
Levothyroxine Sodium233$3,230
Omeprazole183$2,363
Metoprolol Succinate118$2,281

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$129$30,66726 claims
Johnson & JohnsonXarelto$16$19,07413 claims
MerckJanuvia$18$17,73011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 671 adult health providers in Massachusetts.

Other adult health in South Yarmouth

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →